摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1S,2R,3R,4S,6S,7S,9S,13S,16R)-4,7,16-trihydroxy-3,7,11,11,13-pentamethyl-10,12,15-trioxatetracyclo[7.6.1.02,6.013,16]hexadecan-14-one | 776335-10-5

中文名称
——
中文别名
——
英文名称
(1S,2R,3R,4S,6S,7S,9S,13S,16R)-4,7,16-trihydroxy-3,7,11,11,13-pentamethyl-10,12,15-trioxatetracyclo[7.6.1.02,6.013,16]hexadecan-14-one
英文别名
——
(1S,2R,3R,4S,6S,7S,9S,13S,16R)-4,7,16-trihydroxy-3,7,11,11,13-pentamethyl-10,12,15-trioxatetracyclo[7.6.1.02,6.013,16]hexadecan-14-one化学式
CAS
776335-10-5
化学式
C18H28O7
mdl
——
分子量
356.416
InChiKey
DBPXXRLHCUOQKL-XVZUNPEHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    537.8±50.0 °C(Predicted)
  • 密度:
    1.301±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    25
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.94
  • 拓扑面积:
    105
  • 氢给体数:
    3
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Reagents and methods for cancer treatment and prevention
    申请人:Niazi R. Kayvan
    公开号:US20070224207A1
    公开(公告)日:2007-09-27
    The invention generally relates to the prevention and/or treatment of cancer, and, more specifically, to the treatment of tumors, including solid tumors and their metastases, without radiation or standard chemotherapeutic agents. In one embodiment, the invention involves a method comprising: a) providing a subject with tumor cells, b) removing at least a portion of said tumor cells from said subject to create removed cells, c) treating at least a portion of said removed cells ex vivo, using stimulating agents, including thapsigargin and/or thapsigargin-related compounds, so as to create treated tumor cells; and d) introducing said treated tumor cells (or fragments thereof) in vivo into the same subject to generate anticancer therapeutic effects.
    本发明通常涉及预防和/或治疗癌症,更具体地涉及治疗肿瘤,包括实体肿瘤及其转移,而不使用放射线或标准化疗药物。在一种实施方式中,本发明涉及一种方法,包括:a)提供肿瘤细胞给一个受试者,b)从该受试者中去除至少一部分肿瘤细胞以创建去除的细胞,c)使用刺激剂,包括沙环菜素和/或沙环菜素相关化合物,处理至少一部分所去除的细胞外体,以创建处理后的肿瘤细胞;以及d)将所处理的肿瘤细胞(或其碎片)在体内重新引入同一受试者,以产生抗癌治疗效果。
  • Reagents and Methods for Cancer Treatment and Prevention
    申请人:The Buck Institute For Age Research
    公开号:US20160069864A1
    公开(公告)日:2016-03-10
    The invention generally relates to the prevention and/or treatment of cancer, and, more specifically, to the treatment of tumors, including solid tumors and their metastases, without radiation or standard chemotherapeutic agents. In one embodiment, the invention involves a method comprising: a) providing a subject with tumor cells, b) removing at least a portion of said tumor cells from said subject to create removed cells, c) treating at least a portion of said removed cells ex vivo, using stimulating agents, including thapsigargin and/or thapsigargin-related compounds, so as to create treated tumor cells; and d) introducing said treated tumor cells (or fragments thereof) in vivo into the same subject to generate anticancer therapeutic effects.
  • US9107863B2
    申请人:——
    公开号:US9107863B2
    公开(公告)日:2015-08-18
查看更多